NAM
RNAM

Nexpoint Asset Management’s Avidity Biosciences RNAM Stock Holding History

Nexpoint Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-923,950
Closed -$66.6M – 103
2025
Q4 		$66.6M Buy
+923,950
New +$59.7M 4.64% 4

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Nexpoint Asset Management's RNAM Position: Q1 2026 in Review

Nexpoint Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 923,950 shares — an estimated $66.6M sold.

Nexpoint Asset Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $66.6M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Nexpoint Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Nexpoint Asset Management sold 923,950 Avidity Biosciences shares in Q1 2026, an estimated $66.6M.
  • Nexpoint Asset Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Nexpoint Asset Management's Avidity Biosciences position peaked at $66.6M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Nexpoint Asset Management's 13F filing for Q1 2026, filed 15 May 2026.